1 Molinaro AM,Taylor JW,Wiencke JK,et al.Genetic and molecular epidemiology of adult diffuse glioma[J].Nat Rev Neurol,2019,15(7):405-417. 2 Yang MF,Oh IY,Mahanty A,et al.Immunotherapy for glioblastoma:current state,challenges,and future perspectives[J].Cancers(Basel),2020,12(9):2334. 3 van Solinge TS,Nieland L,Chiocca EA,et al.Advances in local therapy for glioblastoma-taking the fight to the tumour[J].Nat Rev Neurol,2022,18(4):221-236. 4 徐洋,秦琪,赵红,等.肿瘤微环境异质性的研究进展[J].实用肿瘤学杂志,2017,31(3):258-261. 5 Hara T,Chanoch-Myers R,Mathewson ND,et al.Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma[J].Cancer Cell,2021,39(6):779-792. 6 Hambardzumyan D,Gutmann DH,Kettenmann H.The role of microglia and macrophages in glioma maintenance and progression[J].Nat Neurosci,2016,19(1):20-27. 7 Shapouri-Moghaddam A,Mohammadian S,Vazini H,et al.Macrophage plasticity,polarization,and function in health and disease[J].J Cell Physiol,2018,233(9):6425-6440. 8 Ginhoux F,Guilliams M.Tissue-resident macrophage ontogeny and homeostasis[J].Immunity,2016,44(3):439-449. 9 Pombo Antunes AR,Scheyltjens I,Lodi F,et al.Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization[J].Nat Neurosci,2021,24(4):595-610. 10 Takenaka MC,Gabriely G,Rothhammer V,et al.Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39[J].Nat Neurosci,2019,22(5):729-740. 11 Geraldo LH,Xu YL,Jacob L,et al.SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia[J].J Clin Invest,2021,131(16):e141083. 12 Wang QW,Sun LH,Zhang Y,et al.MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated,macrophages-mediated immunosuppression in primary glioblastomas[J].J Immunother Cancer,2021,9(10):e002451. 13 Dong F,Qin XY,Wang BF,et al.ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment[J].Cancer Res,2021,81(23):5876-5888. 14 Gangoso E,Southgate B,Bradley L,et al.Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion[J].Cell,2021,184(9):2454-2470. 15 Murray PJ,Allen JE,Biswas SK,et al.Macrophage activation and polarization:nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20. 16 Grabowski MM,Sankey EW,Ryan KJ,et al.Immune suppression in gliomas[J].J Neurooncol,2021,151(1):3-12. 17 Propper DJ,Balkwill FR.Harnessing cytokines and chemokines for cancer therapy[J].Nat Rev Clin Oncol,2022,19(4):237-253. 18 De Boeck A,Ahn BY,D'Mello C,et al.Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression[J].Nat Commun,2020,11(1):4997. 19 Zhai K,Huang Z,Huang Q,et al.Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells[J].Nat Cancer,2021,2(11):1136-1151. 20 Guo Q,Shen S,Guan GF,et al.Cancer cell intrinsic TIM-3 induces glioblastoma progression[J].iScience,2022,25(11):105329. 21 Li ZW,Meng XQ,Wu PF,et al.Glioblastoma cell-derived lncRNA-containing exosomes induce microglia to produce complement C5,promoting chemotherapy resistance[J].Cancer Immunol Res,2021,9(12):1383-1399. 22 Li Z,Fu WJ,Chen XQ,et al.Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization[J].J Exp Clin Cancer Res,2022,41(1):74. 23 张培,曹守波,于雁.自噬介导的肿瘤相关巨噬细胞调控机制的研究进展[J].实用肿瘤学杂志,2018,32(2):130-134. 24 Fukushi A,Kim HD,Chang YC,et al.Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells[J].Int J Mol Sci,2022,23(17):10037. 25 Lu J,Xu ZY,Duan HB,et al.Tumor-associated macrophage interleukin-β promotes glycerol-3-phosphate dehydrogenase activation,glycolysis and tumorigenesis in glioma cells[J].Cancer Sci,2020,111(6):1979-1990. 26 Azambuja JH,Ludwig N,Yerneni SS,et al.Arginase-1+ exosomes from reprogrammed macrophages promote glioblastoma progression[J].Int J Mol Sci,2020,21(11):3990. 27 Zhang X,Chen L,Dang WQ,et al.CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling[J].Lab Invest,2020,100(4):619-629. 28 Yu-Ju Wu C,Chen CH,Lin CY,et al.CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2[J].Neuro Oncol,2020,22(2):253-266. 29 Andreucci E,Peppicelli S,Ruzzolini J,et al.Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry[J].Cancer Metastasis Rev,2022,41(4):935-951. 30 Wei QX,Singh O,Ekinci C,et al.TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy[J].Acta Neuropathol Commun,2021,9(1):67. 31 Ni XG,Wu WC,Sun XQ,et al.Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma[J].Sci Adv,2022,8(27):eabl5165. 32 Blank A,Kremenetskaia I,Urbantat RM,et al.Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma[J].J Pathol,2021,253(2):160-173. 33 Dumas AA,Pomella N,Rosser G,et al.Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment[J].Embo J,2020,39(15):e103790. 34 Campesato LF,Budhu S,Tchaicha J,et al.Blockade of the AHR restricts a treg-macrophage suppressive axis induced by L-kynurenine[J].Nat Commun,2020,11(1):4011. 35 Kesarwani P,Kant S,Zhao Y,et al.Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR/PPARγ signaling axis[J].Nat Commun,2023,14(1):1459. 36 Magri S,Musca B,Pinton L,et al.The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients[J].Int J Cancer,2022,151(12):2265-2277. 37 Ho WS,Mondal I,Xu BS,et al.PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages[J].J Clin Invest,2023,133(6):e162139. 38 Flores-Toro JA,Luo D,Gopinath A,et al.CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas[J].Proc Natl Acad Sci U S A,2020,117(2):1129-1138. 39 Moorman HR,Poschel D,Klement JD,et al.Osteopontin:a key regulator of tumor progression and immunomodulation[J].Cancers(Basel),2020,12(11):3379. 40 Wei J,Marisetty A,Schrand B,et al.Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target[J].J Clin Invest,2019,129(1):137-149. 41 Cui X,Ma C,Vasudevaraja V,et al.Dissecting the immunosuppressive tumor microenvironments in glioblastoma-on-a-chip for optimized PD-1 immunotherapy[J].Elife,2020,9:e52253. 42 Rao R,Han R,Ogurek S,et al.Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition[J].Neuro Oncol,2022,24(4):584-597. 43 Zhang L,Alizadeh D,Van Handel M,et al.Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice[J].Glia,2009,57(13):1458-1467. 44 Liu Y,Li X,Zhang Y,et al.An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme[J].Oncogene,2019,38(49):7399-7415. 45 Peterson TE,Kirkpatrick ND,Huang Y,et al.Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages[J].Proc Natl Acad Sci USA,2016,113(16):4470-4475. 46 Zhang F,Parayath NN,Ene CI,et al.Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers[J].Nat Commun,2019,10(1):3974. 47 von Roemeling CA,Wang Y,Qie Y,et al.Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity[J].Nat Commun,2020,11(1):1508. 48 Jiang N,Xie BW,Xiao WW,et al.Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion[J].Nat Commun,2022,13(1):1511. 49 Chen Y,Yu Z,Tan X,et al.CAR-macrophage:a new immunotherapy candidate against solid tumors[J].Biomed Pharmacother,2021,139:111605. 50 Chen C,Jing W,Chen Y,et al.Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy[J].Sci Transl Med,2022,14(656):1128. |